Browse Negotiations Image Banner

Banner Text Velit velaliquam, ultricies eros dolore magna in in doming ullamco sint. Sint doming dignissim in quis pariatur consequat urna eu providerent. Sint dolore ea urna velit doming ea pulvinar.

General Callout

Nunc dolor esse suscipit eros eros ullamco dolor. Duis velaliquam sunt urna, tempuribud doming quis, laboris ultricies ultricies urna laboris. Nostrud pulvinar nostrud elit sunt ex exercitation magna tempuribud laboris ea ex nunc sed exercitation ea laboris dignissim.

Accordion

Quis harmud ea commodo voluptate dolor urna providerent tempor amet dignissim velit consectetur harmud sint doming, urna magna velit sed commodo urna sint sunt nunc. Nunc consectetur laboris harmud dolore exercitation sed magna laboris nulla velit velaliquam ultricies. Dignissim adipiscing, sed duis ultricies sint voluptate providerent nunc nisi.

Heading 1

Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.

Heading 2

Pariatur aliquip quis doming sint eros sit nulla consectetur velit quis consectetur ea dolore quis, eros voluptate commodo quis doming sint aliquip esse tempuribud quis velit ut ut aliquip ex quis, ullamco eu in. Nisi nulla amet quis tempor tempuribud aliquip. Adipiscing nostrud eu fugiat, duis quis sunt eu, providerent sed quis pariatur velit amet dolore in.

Related content

Dolor commodo suscipit adipiscing suscipit, elit dolore velit. Amet tempuribud velit pariatur ullamco exercitation esse dolore sint velaliquam adipiscing eu pulvinar doming sunt, dignissim velit voluptate ex suscipit sunt ex, duis dignissim nunc tempuribud laboris commodo velit ut. Velit in harmud quis voluptate esse nulla.

Shop Now!

Laboris quis consectetur sed eros velit tempuribud suscipit magna ea consequat laboris. Elit adipiscing quis sunt duis magna nulla velit amet elit ex providerent consectetur tempuribud amet ex commodo urna, magna adipiscing elit sed duis nisi pulvinar, doming pariatur velaliquam quis providerent fugiat ea aliquip sit ut nisi sunt pulvinar eu velit.

grey rec centre

Call to action

Esse suscipit in eros ea sed voluptate dolore, harmud nisi, dolore ultricies fugiat amet doming ut sint ut adipiscing. Sit velit velaliquam ex nunc ut voluptate

Primary Button Secondary Button

Search by drug, manufacturer, or indication

Displaying 1041 - 1050 of 1165

Janumet (sitagliptin phosphate)

Status:

Concluded with an LOI

Manufacturer:

Merck Canada Inc.

Indication:

Diabetes Mellitus, Type 2

Last updated February 8, 2016

Zykadia (ceritinib)

Status:

Negotiations were not pursued

Manufacturer:

Novartis Pharmaceuticals Canada Inc.

Indication:

Non-Small Cell Lung Cancer (metastatic)

Last updated February 5, 2016

Cimzia (certolizumab pegol)

Status:

Concluded with an LOI

Manufacturer:

UCB Canada Inc.

Indication:

Ankylosing spondylitis

Last updated January 6, 2016

Opsumit (macitentan)

Status:

Concluded without agreement

Manufacturer:

Actelion Pharmaceuticals Ltd.

Indication:

Pulmonary Arterial Hypertension

Last updated December 18, 2015

Actemra SC (tocilizumab)

Status:

Concluded with an LOI

Manufacturer:

Hoffmann-La Roche Ltd.

Indication:

Rheumatoid Arthritis

Last updated December 16, 2015

Incruse Ellipta (umeclidinium)

Status:

Concluded with an LOI

Manufacturer:

GlaxoSmithKline Inc.

Indication:

Chronic Obstructive Pulmonary Disease (COPD)

Last updated December 15, 2015

Duaklir Genuair (aclidinium bromide/formoterol fumarate dihydrate)

Status:

Concluded with an LOI

Manufacturer:

AstraZeneca Canada Inc.

Indication:

Chronic Obstructive Pulmonary Disease (COPD)

Last updated December 15, 2015

Inflectra (infliximab)

Status:

Concluded with an LOI

Manufacturer:

Hospira Healthcare Corporation

Indication:

Ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis

Last updated November 19, 2015

Bosulif (bosutinib)

Status:

Concluded with an LOI

Manufacturer:

Pfizer Canada ULC

Indication:

Chronic Myeloid Leukemia

Last updated November 9, 2015

Avastin (bevacizumab)

Status:

Concluded with an LOI

Manufacturer:

Hoffmann-La Roche Ltd.

Indication:

Cervical Cancer

Last updated November 4, 2015